(1)
Evaluation of the Bioequivalence of Two Formulations Containing the Combination of 400 Mg of Acetaminophen (paracetamol), 4 Mg of Phenylephrine and 4 Mg of Chlorpheniramine in Capsules: Open-Label, Three-Way Crossover Study, Partially Replicated in Health. Braz. J. Pharm. Sci. 2020, 56, e17836 . https://doi.org/10.1590/s2175-97902020000217836.